VR-CBT With Inuit in Quebec
A Virtual Reality-assisted Cognitive Behavior Therapy With Inuit in Quebec - a Proof-of-concept Randomized Controlled Trial
1 other identifier
interventional
40
1 country
1
Brief Summary
The study design is a two-arm randomized controlled pilot trial. The investigators will recruit Inuit in Montreal and randomly assign them to two treatment groups (n=20 each). The active psychotherapy group will receive a ten-week manualized virtual reality (VR) assisted cognitive-behavioral psychotherapy (VR-CBT) at the clinic and guided by a psychotherapist. The VR-CBT will aim at improving emotion regulation. The comparison group will use a VR self-management program, Calm Place, for guided relaxation during ten weeks at home. To evaluate outcome in both groups, the researchers will measure self-reports of emotion regulation, affect, distress and well-being, as well as a psychophysiological reactivity paradigm pre-post treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 21, 2022
CompletedFirst Posted
Study publicly available on registry
November 30, 2022
CompletedStudy Start
First participant enrolled
July 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedFebruary 12, 2025
February 1, 2025
2.3 years
October 21, 2022
February 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Emotion Regulation
Difficulties in Emotion Regulation Scale-16 is a short, valid measure of emotion regulation, scored from 16(low difficulties)-80 (higher difficulties).
Approximately 5 minutes
Secondary Outcomes (15)
heart rate
Approximately 1 hour testing session.
heart rate variability
Approximately 1 hour testing session.
skin conductance response
Approximately 1 hour testing session.
anxiety (momentary)
Approximately 1 hour testing session.
emotional arousal (momentary)
Approximately 1 hour testing session.
- +10 more secondary outcomes
Study Arms (2)
VR-CBT
EXPERIMENTALA trained psychotherapist provides CBT-VR for up to 10 sessions over 10 weeks.
Self-management
ACTIVE COMPARATORParticipants use a commercial VR application at home for guided self-management at their own pace over 10 weeks.
Interventions
The therapy is focused on emotion regulation through guided learning in virtual reality. The manual is a modified conventional cognitive behavioral therapy to include these aspects and the suggestions of an advisory committee of Inuit and non-Inuit health service providers (e.g., cultural adaptation).
The previously developed commercial VR program involves guided relaxation and meditation techniques.
Eligibility Criteria
You may qualify if:
- Self-identify as Inuk
- Live in Montreal
- be between 14 to 60 years of age
- be proficient in English or French
- No history of cardiac conditions
- No history of epilepsy
- Can provide an emergency contact
- Tolerance of VR headset
- Tolerance of sensors
- Has no current suicidal or homicidal risk
- No history of psychosis or schizophrenia
- Current stable mood
- Is generally mentally stable
- Score less than 8 on the Alcohol Use Disorders Identification Test C
- Score less than 3 on the Drug Abuse Screen Test (10 item version)
You may not qualify if:
- does not identify as Inuk
- youth below the age of 14 and adults above the age of 60.
- self-reported history of psychosis or schizophrenia
- current substance abuse, as measured by two screens (AUDIT-C, DAST-10)
- other mental or physical condition that might preclude them from the trial (i.e., pre-existing heart conditions, convulsions, acute mental health risk).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Douglas Mental Health University Institutelead
- Natural Sciences and Engineering Research Council, Canadacollaborator
- MedTeqcollaborator
- Douglas Foundationcollaborator
- McGill Universitycollaborator
Study Sites (1)
Douglas Mental Health University Institute
Montreal, Quebec, h4h 1r3, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Outi Linnaranta, MD, Ph.D
Douglas Mental Health University Institute
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- James McGill professor
Study Record Dates
First Submitted
October 21, 2022
First Posted
November 30, 2022
Study Start
July 15, 2023
Primary Completion
October 31, 2025
Study Completion
December 31, 2025
Last Updated
February 12, 2025
Record last verified: 2025-02